Gudesblatt, Mark http://orcid.org/0000-0002-3700-8554
Bumstead, Barbara
Buhse, Marijean
Zarif, Myassar
Morrow, Sarah A.
Nicholas, Jacqueline A.
Hancock, Laura M.
Wilken, Jeffrey
Weller, Joanna
Scott, Nicole
Gocke, Anne
Lewin, James B.
Kaczmarek, Olivia
Mendoza, Jason P.
Golan, Daniel
Funding for this research was provided by:
Biogen
Article History
Received: 13 November 2023
Accepted: 14 May 2024
First Online: 11 June 2024
Declarations
:
: Mark Gudesblatt: speaker and consulting for Acorda, Amgen, Biogen, EMD Serono, Medtronic, Novartis, Sanofi Genzyme, Saol Therapeutics, and Teva Pharmaceuticals. Daniel Golan: Speaker and consulting for Bristol Myers Squib, Medison, Merck Serono, Novartis, and Roche. Barbara Bumstead: speaker and consulting for Biogen and BMS. Marijean Buhse: speaker and consulting for Biogen and Genzyme. Myassar Zarif: speaker and consulting for Biogen, BMS, EMD Serono, Horizon, Genentech, Novartis, and Sanofi. Sarah A. Morrow: served on advisory boards for Biogen Idec, EMD Serono, Novartis, Roche, and Sanofi Genzyme; received investigator-initiated grant funds from Biogen Idec, Roche, and Sanofi Genzyme; acted as site PI for multi-center trials funded by BMS, EMD Serono, Novartis, Roche, and Sanofi Genzyme; and received funding from CIHR, MSSC, and NMSS. Dr. Morrow’s new affiliation is Department of Clinical Neurosciences, University of Calgary, Hotchkiss Brain Institute, Calgary, AB, Canada. The affiliation listed in the title was Dr. Morrow’s affiliation at the time of the study. Jacqueline A. Nicholas: has received consultancy fees from Bristol Myers Squibb, EMD Serono, Genentech, MyMSTeam, Novartis, Octave Bio and TG Therapeutics; has received research support from Novartis, Genentech, Alexion, Octave Bio, Sanofi Genzyme, University of Buffalo and PCORI; serves on speakers’ bureau for EMD Serono and TG Therapeutics. Laura M. Hancock: research support from BMS, Clinical & Translational Science Institute and Advancing a Healthier Wisconsin Research and Education Program, and NIH; and speaker honoraria from Can Do MS, the. MS Association of America, and the National MS Society of America. Jeffrey Wilken: nothing to disclose. Nicole Scott, Anne Gocke, James B. Lewin, and Jason P. Mendoza: employees of and hold stock/stock options in Biogen. Olivia Kaczmarek: nothing to disclose. Joanna Weller: nothing to disclose.
: The study was conducted according to local regulations and in compliance with the principles of the Declaration of Helsinki 1964. All instructions, regulations, and agreements of the protocol, and applicable International Conference on Harmonisation guidelines, were adhered to, and the study protocol was approved by the Institutional review board (IRB). Because this was a retrospective cohort study, based on routinely collected clinical data in a coded database, informed consent has been waived by the IRB.